## **Core Concept**
Enalapril is an **angiotensin-converting enzyme (ACE) inhibitor** used primarily in the treatment of **essential hypertension** and certain types of heart failure. ACE inhibitors work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby relaxing blood vessels and reducing blood pressure.

## **Why the Correct Answer is Right**
The correct answer, , states that enalapril **increases bradykinin levels**. This is accurate because ACE is also responsible for the breakdown of bradykinin, a peptide that causes vasodilation and increased vascular permeability. By inhibiting ACE, enalapril reduces the breakdown of bradykinin, leading to its accumulation. Increased bradykinin levels contribute to the therapeutic effects of ACE inhibitors, including vasodilation and a decrease in blood pressure.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because enalapril **does not significantly increase angiotensin II levels**; instead, it decreases them by preventing the conversion of angiotensin I to angiotensin II.
- **Option B:** This option is incorrect as enalapril **does not primarily act by stimulating the release of atrial natriuretic peptide (ANP)**, although some effects on sodium excretion and blood pressure could indirectly relate to ANP activity.
- **Option C:** This option might seem plausible but is not the best answer given the context of the question focusing on a direct effect related to enalapril's mechanism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ACE inhibitors like enalapril are **contraindicated in pregnancy**, particularly in the second and third trimesters, due to the risk of fetal renal damage and other complications. They are also known for causing a **dry cough** in some patients, a side effect thought to be related to the increased bradykinin levels.

## **Correct Answer:** . increases bradykinin levels.